CAAS Capital Management’s Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share PIAI.U Stock Holding History
Bought
Maintained
Sold
Other funds holding PIAI.U
BCM
HP
GCL
HF
MS
HIM
WC
CL
CIM
CAAS Capital Management's PIAI.U Position: Q2 2021 in Review
CAAS Capital Management sold out of Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share (PIAI.U) in Q2 2021, closing a stake of 600,000 shares — an estimated $5.94M sold.
CAAS Capital Management first reported a position in PIAI.U in Q3 2020 and held it in 3 quarters. The position peaked at $6.37M in Q4 2020. 22 funds tracked by Wall St. Rank hold PIAI.U as of Q2 2021.
- CAAS Capital Management reported no remaining Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share position as of Q2 2021 after selling out during the quarter.
- CAAS Capital Management sold 600,000 Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share shares in Q2 2021, an estimated $5.94M.
- CAAS Capital Management first reported a position in Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share in Q3 2020 and held it in 3 quarters.
- CAAS Capital Management's Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share position peaked at $6.37M in Q4 2020.
- 22 funds tracked by Wall St. Rank held Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share as of Q2 2021.
Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.